MABPRO, a.s. at Turin LIFTT Conference 2025
MABPRO, a.s. presented its results, goals and vision at the Slovak-Italian LIFTT conference in Turin, intended for start-ups. MABPRO, a.s. was represented in Turin by Vice President Clinical Research Richard Imrich. You can watch the report from the conference, which was also attended by President Peter Pellegrini, in the STVR archive under the title “Slovaks presented innovations in Turin“.
Turin LIFTT Conference 2025, Italy
MABPRO, a.s. at HypoxEU LIVE 2024 in Dresden
MABPRO participated in the HypoxEU LIVE 2024 meeting, held from June 9–12, 2024 in Dresden, Germany, where the company presented a scientific poster titled “Humanized monoclonal antibodies specific for CA IX protein are able to suppress hypoxia.”
The presentation showcased MABPRO’s latest research in the field of tumor hypoxia and targeted cancer therapies.
9-12 June 2024, Dresden, Germany, HypoxEU LIVE
MABPRO, a.s. Presented at EAU 2024 Congress
From April 5–8, 2024, MABPRO proudly participated in the 39th Annual Congress of the European Association of Urology (EAU), one of the most renowned events in the field of urology. As part of our ongoing commitment to advancing cancer research, we presented a scientific poster titled “Carbonic anhydrase IX in renal cell carcinoma: a relevant biomarker and promising therapeutic target.”
5-8 April 2024, Paris, France, European Association of Urology (EAU)
Rozhovor v Rádiu Slovensko
V sobotu 24. augusta 2024 bola profesorka Silvia Pastoreková hosťom v relácii Hosť sobotného Dobrého rána v Rádiu Slovensko. S moderátorkou Katou Martinkovou sa rozprávali o histórii a význame bielkoviny CA9 pre diagnostiku a liečbu nádorových ochorení, ale aj o organizácii European Molecular Biology, do ktorej ju nedávno zvolili ako prvú zástupkyňu slovenskej vedeckej obce.
Slovenská televízia a rozhlas, Mlynská dolina, 845 45 Bratislava, Slovenská republika
